Hydrogen/Oxygen Mixed Gas Inhalation for Coronavirus Disease 2019 (COVID-19)

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

January 21, 2020

Primary Completion Date

March 23, 2020

Study Completion Date

March 23, 2020

Conditions
Covid-19Hydrogen/Oxygen Mixed GasDyspnea
Interventions
DEVICE

Hydrogen Oxygen Generator with Nebulizer

Patients in treatment group inhaled H2-O2 (66% hydrogen; 33% oxygen) at 3 L/min via nasal cannula by using the Hydrogen/Oxygen Generator (model AMS-H-03, Shanghai Asclepius Meditech Co., Ltd., China) until discharge.

OTHER

Standard-of-care

Standard-of-care consisted of the supportive therapies (including oxygen therapy) recommended by the Chinese National Health Commission

Trial Locations (1)

Unknown

First Affiliated Hospital of Guangzhou Medical University, Guangzhou

All Listed Sponsors
lead

Guangzhou Institute of Respiratory Disease

OTHER

NCT04378712 - Hydrogen/Oxygen Mixed Gas Inhalation for Coronavirus Disease 2019 (COVID-19) | Biotech Hunter | Biotech Hunter